Cosmo Pharmaceuticals N.V. (CMOPF)

Cosmo Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,384	1,128	972	1,084	1,212	1,390
Market Cap Growth	106.22%	16.07%	-10.39%	-10.51%	-12.80%	19.98%
Enterprise Value	2,243	995	926	1,041	1,170	1,305
Last Close Price	151.00	66.93	52.65	68.90	72.45	89.20
PE Ratio	33.85	8.18	-	58.91	49.16	-
PS Ratio	11.14	4.08	9.48	9.94	16.37	18.64
PB Ratio	4.35	2.16	2.18	2.19	2.08	2.84
P/TBV Ratio	18.96	3.48	3.43	14.09	9.52	2.87
P/FCF Ratio	29.97	6.90	45.41	35.34	149.55	128.14
P/OCF Ratio	27.62	6.71	38.72	30.54	84.48	87.48
EV/Sales Ratio	10.16	3.60	9.03	9.54	15.80	17.50
EV/EBITDA Ratio	22.82	5.99	90.38	23.65	57.74	176.12
EV/EBIT Ratio	26.95	6.46	-	34.71	92.64	590.89
EV/FCF Ratio	28.18	6.09	43.26	33.92	144.35	120.31
Debt / Equity Ratio	0.01	0.00	0.01	0.37	0.33	0.42
Debt / EBITDA Ratio	0.03	0.01	0.18	4.14	9.20	24.49
Debt / FCF Ratio	0.04	0.01	0.10	6.05	23.85	18.97
Asset Turnover	0.29	0.46	0.14	0.13	0.09	0.10
Inventory Turnover	3.64	3.27	3.06	3.29	3.50	4.66
Quick Ratio	3.59	3.39	3.22	1.45	11.77	11.06
Current Ratio	3.84	4.19	4.07	1.57	12.99	11.60
Return on Equity (ROE)	12.34%	29.31%	-2.47%	3.58%	4.75%	-1.99%
Return on Assets (ROA)	6.88%	15.87%	-0.18%	2.24%	0.99%	0.19%
Return on Invested Capital (ROIC)	16.65%	35.94%	-0.50%	4.68%	2.46%	0.56%
Return on Capital Employed (ROCE)	12.20%	24.90%	-0.40%	5.00%	1.40%	0.30%
Earnings Yield	2.95%	12.23%	-1.23%	1.70%	2.03%	-0.70%
FCF Yield	3.34%	14.49%	2.20%	2.83%	0.67%	0.78%
Dividend Yield	-	3.17%	4.20%	1.63%	1.49%	-
Payout Ratio	94.36%	24.09%	-	90.61%	-	-
Buyback Yield / Dilution	-1.65%	-1.94%	1.95%	2.83%	-16.81%	1.11%
Total Shareholder Return	-1.65%	1.23%	6.15%	4.46%	-15.32%	1.11%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.